NuvaRing, 0.120 mg/0.015 mg per 24 hours, Vaginal delivery system

  • DHPC
Active Ingredient
Strength
  • Ethinylestradiol: –
  • Etonogestrel: –
Dosage Form
Vaginal delivery system
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
Additional Communications section shown.

Direct Healthcare Professional Communications

  • Signal assessment on meningioma risk

    Direct Healthcare Professional Communication (DHPC)

    PDF210.91 KB

Organon Pharma (Ireland) Limited

2 Dublin Landings, N Wall Quay - North Dock, Dublin, D01 V4A3

Telephone
+35315828260